ads
ARTH2

Arch Therapeutics Inc (ARTH) – updated research report

 

Screen Shot 2013-06-17 at 4.24.32 PM

 

We already considered Arch Therapeutics Inc (ARTH) a future paid promotion stock publishing a report on the ticker on May 29, 2013 and adding it to our list of tickers to watch for a future paid promotion.  See that report here.  Over the past few days, since that report, we saw ARTH start trading for the first time, the company website go live, and a new video for the company show up on youtube.  

After some sporadic volume over the past 7 trading days, things suddenly got really interesting today for Arch Therapeutics Inc (ARTH).  We noticed the price being knocked down on small blocks from $.86/share to $.75/share then after a 50,000 shares block went off at $.76, I decided to scan around to see if there were any signs of a paid promotion finally getting closer for ARTH.   What I found was a domain that is obviously set up to be used for a future paid promotion for ARTH at arthreport.com.

The domain was registered via private proxy on June 13, 2013.  The domain is currently set to private to avoid public traffic from being able to view what is on the page.  To eliminate the possibility that the domain was just registered by somebody as a joke or to mislead, I did a IP/Server search on the domain and found that the domain shares the same Server/IP as 6 other previous stock promotion websites:

a

orynreport.com – ORYN was a Jim Hyerczyk / Paragon / Bedford promotion in May of 2012 that went from $.75/share to $1.33/share.

grphreports.com – GRPH was a Jim Hyerczyk / Paragon / Bedford promotion in October of 2012 that went from $.86/share to $.93/share.

ecaureports.com – ECAU was Chuck Hughes / Paragon / Bedford promotion in January of 2013 that went from $.80/share to $3.61/share.

tungreport.com – TUNG was a Daniel Ameduri and CFM promotion in April of 2013 that went from $.91/share to $1.50/share.

tqlareport.com – TQLA was a Andrew Carpenter promotion in May of 2013 that went from $.87/share to $.95/share.

norxreport.com – NORX was an Eric Dany promotion in April/May/June of 2013 that went from $.52/share to $2.06/share.

a

Just sharing the same IP/Server of these past promotions doesn’t narrow down the type of promotion we can expect yet.

We do have one other clue though – a video for ARTH that was published on youtube.  Originally an ARTH video was posted on youtube on June 10, 2013 which we found after just 2 viewers had seen it, but that video originally found here was taken down.  Instead on June 13, 2013, the same day that the arthreport domain was registered, a new ARTH video was posted on you tube found here.

All but the TQLA promotion page from the list above had videos.  Compare them below:

a

ARTH:

a

a

TUNG

a

a

ECAU

a

a

GRPH

a
a

a

So we have definitely linked ARTH to past promotions and have pretty much no doubt that ARTH will be a promoted ticker.  We are hoping it will be a Chuck Hughes mailer like ECAU, but until the landing page goes live we will not know for sure.  So how soon until the promo starts?

The trading action today gives us an idea.  After the first 50,000 block went off at $.76/share and speculation buyers started buying into the stock, we started seeing many more big blocks go through at the $.76/share level including a huge after hours t trade.  Judging by all of the huge blocks, the paid promotion will probably be sooner rather than later. 

a

Screen Shot 2013-06-17 at 6.25.33 PM

a

The current $.77/share price would be the lowest starting point of all past promotions linked to this group so it seems like a safe entry, but understand that there are always risks with buying into a promotion before the promotion starts including a possible shake out of front loaders.

 

 

The following is  a re-post of our May 29, 2013 ARTH research report including a couple of small updates that have happened since May 29, 2013 when we wrote our originally report.

 

Recently AAHC which is still an infant ticker has been going through some major changes including a merger agreement, change of control, name change to Arch Therapeutics, and an 11:1 forward split.  Because of all of these big changes I decided to take a closer look at AAHC.

a

The Set-up

AAHC was originally set up as a Nevada business entity on September 16, 2009 with Daniel Kramer as the sole officer/director and incorporator of the shell.  The original name of the company was Almah Inc.  Kramer has been involved in setting up dozens of shells as a managing member of Val-U-Corp Services Inc.  Shortly after being incorporated, Joey Power of Ireland took over as the sole officer/director of the shell.

Joey Power was a 34 year old auto mechanic working for Denis Henderson Car Garage in Cork City, Ireland when he was given the nominee role of CEO of Almah Inc.  Cork City is the same area of Ireland that the O’Flynn family resides (GOFF and MBGI) – see this report for more details.

Joey Power was issued 4,000,000 shares of stock for $20,000.

a

Going Public

On January 5, 2012, an S-1 was filed to take Almah Inc public.

The forward looking business plan was to distribute auto spare parts online at almahautoparts.com.  To help make the business plan work, Almah Inc signed an agreement with Veleo Service Export to resell Veleo auto parts.  The website (almahautoparts.com) was never made public and is long ago expired, but I was able to locate the original IP server for the site and it was no big surprise to me to find out that one of the other domains that shared the same server was kenoflynn.com.

a

Screen Shot 2013-05-29 at 6.40.19 PM

a

This is the same Ken O’Flynn that we already linked to GOFF and MBGI as this archived link for the website proves.  Again see our MBGI report for more details.

a

Screen Shot 2013-05-29 at 6.47.10 PM

a

The attorney helping with the S-1 filing was Synergy Law Group (Kristen A Baracy).  Other Synergy Law tickers include AAVC, CHLL, JUHL, LCMD, PVEN, STTX, VRCV, and Zewar Jewellery Inc.

The accountant helping with the S-1 filing was Paritz and Company P.A.

The S-1 filing was made effective on March 2, 2012.

a

Seed shareholders

During April and May of 2012, Almah Inc sold 2,030,000 shares to a group of 29 anonymous seed shareholders for $.01/share raising $20,300.

a

Merger/Change of Control

Almah Inc never managed to sell even one single auto part, but since Almah Inc wasn’t taken public to have a real business but rather to issue cheap shares to anonymous insiders to be sold later for huge profits this should be no surprise.   By March 31, 2013, AAHC was down to just $52 cash and it was time to put the next stage of this insider enrichment scheme into motion.

On April 19, 2013, Almah Inc signed a Letter of Intent with Arch Therapeutics Inc (a Massachusetts entity).  AAHC agreed to acquire all of the issued and outstanding capital stock and convertible notes and warrants of Arch Therapeutics Inc in exchange for 20,000,000 shares of AAHC common stock.

Also as part of the agreement, AAHC agreed to pay off a $250,000 Promissory Note for Arch Therapeutics Inc and to raise an additional $1,000,000 for Arch Therapeutics through the sale of AAHC stock at $.50/share to Coldstream Summit Ltd.  The AAHC filings do not disclose who controls Coldstream Summit Ltd or anything about the entity.  All we know is that Coldstream Summit Ltd is a foreign entity which is another red flag for a possible future paid promotion.

Coinciding with the signing of the Letter of Intent, Joe Powers resigned from all of his positions.  Terrence W. Norchi, M.D. and Avtar Dhillon, M.D were appointed to the Board of Directors.  Terrence W. Norchi M.D. became the new CEO, president, CFO, treasurer, and secretary for AAHC.

Terrence W. Norchi, M.D. is a board certified Internal Medicine specialist.   Dr. Norchi became the President of Arch Therapeutics Inc in 2006.

Avtar Dhillon, M.D. is also the Chairman of Stevia First Corp (STVF) and a director for OncoSec Medical (ONCS).  STVF was promoted by Bedford/Paragon starting on March 13, 2012.  ONCS was promoted by Capital Financial Media (CFM) on March 11, 2012.  Besides his roles with pump & dump penny stocks, Dr. Dhillon also sits on the Board of Directors of BC Advantage Funds, a very large Venture Capital Corporation in British Columbia

a

Forward Split / Name Change

On May 13, 2013 as the Merger Agreement was going through its final stages of completion, AAHC raised its authorized share count from 75,000,000 to 300,000,000 and changed the name of the entity to Arch Therapeutics Inc with the Nevada SOS.

The authorized share increase was done to make room for an 11:1 forward split which cleared yesterday, May 28, 2013.

The name change will probably be accompanied with a symbol change which is still being reviewed by FINRA.

After the 11:1 forward split the AAHC share structure looks as follows:

Authorized – 300,000,000 shares
Outstanding – 66,330,000 shares
Joey Power – 44,000,000 shares
Seed shareholders – 22,330,000 shares (free trading) – costing $.009/share.

 

Once the merger agreement is completed, the Arch Therapeutics Inc (Massachusetts) shareholders will have 20,000,000 shares bringing the outstanding share count up to 88,330,000 shares.  Most likely we’ll see Joey Power cancel most (if not all) of his shares once the merger is officially closed.  We’ll also see shares start getting sold to the foreign entity, Coldstream Summit Ltd.

a

More about Arch Therapeutics Inc

Arch Therapeutics Inc was incorporated as a Massachusetts entity on March 6, 2006 as Clear Nano Solutions Inc.  The founder of the entity was Steve Kelly who was a telecommunications professional.  See this article for more information.  The business plan for Clear Nano Solutions Inc was to develop a biodegradable liquid containing nanoscale peptides that self-assemble into a gel over open cuts to stop bleeding within seconds.  Shortly after founding Clear Nano Solutions Inc, Steve Kelly hired Dr. Terrence W Norchi M.D. to be the president of the entity.  

Clear Nano Solutions Inc (nka Arch Technologies Inc) has twice filed with the SEC to do public offerings see here and here so it should be no surprise that they would eventually sign an agreement for a reverse merger to go public.

On April 7, 2008 the name of the entity was changed from Clear Nano Solutions Inc to Arch Therapeutics Inc.  Since December 23, 2010, Steve Kelly has no longer been a part of the entity.

At one time through on of its earliest officers, Rutledge Ellis-Behnke, Clear Nano Solutions Inc had a patent found here related to their nanoscale peptide technology.  What the current business operations of Arch Therapeutics Inc now consist of we cannot be sure until they file their balance sheet and disclosure.  Arch Technologies Inc doesn’t even have a current website.  The website found here is under construction.  The following screen shot is what the website used to look like from 2008 – 2012:

a

Screen Shot 2013-05-29 at 8.10.01 PM

a

a

What to expect next

The merger still hasn’t officially closed yet, but we’ll probably see the merger close soon.  We may see Joey Power cancel some (if not all) of his shares.  At some point the name change to Arch Therapeutics Inc will be approve by FINRA along with a symbol change.  As long as the terms don’t change, AAHC will be selling shares to the anonymous foreign business entity, Coldstream Summit Ltd at $.50/share.  This gives us a pretty good idea that the share price for AAHC will be trading north of $.50/share on the public market.

Archer Therapeutics Inc will bring a pretty snazzy story line/business operation to the AAHC shell, but the real story for AAHC is the involvement of the O’Flynn family with setting up the shell and the 22,330,000 free trading seed shareholder shares costing just $.009/share.  This combination makes AAHC a good candidate for a future paid promotion – probably a newsletter/hard mailer type promotion.  Before any major awareness starts, we’ll see the AAHC website go live again.

 

Since March 29, 2013

 

Name/Symbol Change

On June 5, 2013, Almah Inc (AACT) officially became Arch Therapeutics Inc (ARTH).

 

Website Goes Live

On June 8, 2013, the new ARTH website went live found here.  It was a huge improvement over the website in the past.

 

Promotion is set-up

On June 10, 2013, a video is published for ARTH.  The video is later moved on June 13, 2013, but can now be found here.

We expect to see that video show up on the landing page in waiting at arthreport.com which was registered on June 13, 2013, but currently remains private.

Once the landing page goes live, we’ll know for sure who is promoting ARTH and the promotion will officially have started.  I’m expecting to see the landing page go live before the end of the week – probably sooner rather than later.

With ARTH insider Avtar Dhillon’s link to a former Bedford/Paragon promotion, STFV, and the landing page link to two past Bedford/Paragon promotions, ECAU and GRPH, promo hunters will be hoping for ARTH to become a Chuck Hughes/Bedford/Paragon promotion similar to STFV and ECAU.  Unfortunately only time will tell for sure.

 

 

 

 

 

4 Responses to Arch Therapeutics Inc (ARTH) – updated research report

  1. nodummy nodummy says:

    On June 26, 2013, the ARTH merger officially closed.

    http://www.sec.gov/Archives/edgar/data/1537561/000114420413036721/v348159_8k.htm

    As already mentioned in our report a foreign business entity called Coldstream Summit Ltd received stock at $.50/share. To date Coldstream has received 2,500,000 shares for proceeds of $1,250,000.

    14,645,212 new shares were issued in the share exchange bringing the total outstanding share count for ARTH to 58,645,212 shares.

    Prior to the closing of the merger, John Powers must have cancelled some of his 44,000,000 shares. What we do know is that following the merger the new ARTH share structure looks as follows:

    Authorized – 300,000,000 shares
    Outstanding – 58,645,212 shares
    Coldstream – 1,250,000 shares
    Seed Shareholders (free trading) – 22,330,000 shares
    Terrence Norshi – 11,419,076 shares
    Avtar Dhillon – 7,160,373 shares
    Arthur Rosenthal – 58,400 shares
    Alan Barber – 225,000 shares
    Anonymous Arch Therapeutics debt holders – 9,000,000 shares
    Unknown – 7,202,363 shares

    Avtar Dhillon is the new Chairman of the Board
    Terrence Norshi is the new CEO
    Alan T. Barber is the new CFO
    Arthur Rosenthal is a new director

    The Arch Therapeutic balance sheet for the period ending March 31, 2013 was pitiful looking with $2,063 in assets, $3,152,391 in liabilities, and $0 in revenues.

    http://www.sec.gov/Archives/edgar/data/1537561/000114420413036721/v348159_ex99-2.htm

    ARTH is now fully ready for that future paid promotion which we expect to see start in the near future.

  2. nodummy nodummy says:

    Additional Info on the ARTH promotion released by us in a separate report on Saturday morning

    http://promotionstocksecrets.com/arth-landing-pages-are-live-again/

  3. Sp says:

    Hi – How did you do an ip/server search to find the 6 other domains that ip was shred with?

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>